Altered production and utilization of SCFAs occurs when gut flora is dysbiotic, e.g., reduced butyrate-producing bacteria and decreased butyric acid levels in patients with inflammatory bowel disease, and this change may lead to abnormal immune cell function, making CD8+ T cells more susceptible to activation to attack melanocytes. This evidence concerns the gene CD8A and inflammatory bowel disease.